I see the purpose behind the questions you ask. I have had many of the same questions.

I do NOT know all of what is going on behind the scenes at BioAgra, nor do I wish to know. However, there is a network of scientists that is associated with BioAgra in some capacity. (It should be fairly obvious that a former securities lawyer turned CEO of a nanotech company, the former head of a trucking company in New Jersey, and the manager of a building supply company are not the scientific minds behind BioAgra.)

There is much more here than meets the eye, and for some reason, BioAgra is holding the scientific information close to the chest. I have no doubt as to the EXISTANCE of scientific minds behind the JV, based on what I saw in Hinesville, and the familiarity of the staff with the scientific aspects of the operation. The technical director, and his/her staff, seem to be ``invisible``.

Here`s what I DO know:

1) Some of the authors of the patent application for the YBG process have been loosely associated with other Beta glucan researchers over the past decade or so. The mind behind Progressive BioActives in Canada, for example, was formerly with the Canadian division of another company, loosly associated with others on the patent application. There is a network of scientists who have made this their life`s work.

2) A lot of the Beta glucan research, and even marketing over the past decade or two, has taken place in Asia, in particular in Japan. Several prominant Beta Glucan scientist from the US have worked extensively in Asia, for as much as six months out of the year, doing their work. The research in Asia is ongoing.

3) Because the MD`s and PhD`s doing this research are also frequently associated with research institutions and Universities and Medical Schools, there is naturally an even larger network of students doing the work and other researchers following the published results.

4) I have no idea who is formally aligned with whom in this network, but get the impression that most of these people work with, or HAVE worked with the other scientists in their field, and that the boundaries are not as distinct in the academic and research fields as they might be in the corporate arena.

5) I suspect that it may be through the above referenced relationships that the ``operations`` continue. Dr. Young Park, apparantly, is ONE of the researchers who has chosen to become aligned with BioAgra, and who is formally working to introduce YBG-2000 into clinical trials and testing related to the H5N1 virus in Asia. (Asia seems to be a lot more anxious to do this work, because of the prominance of Avian Influenza outbreaks there. The US seems reluctant to have clinical trials going on, because of the high risk of introducing an outbreak. Thus far, we have escaped incidence of the H5N1 virus strain that is threatening Asia.)

6) I would love to know who all the scientific minds are behind the scenes at BioAgra, but I suspect that information will only be disclosed when BioAgra is prepared to do so. EVEN THEN, because of the nature of this industry, we may not know who is contributing research data to BioAgra when the R&D department is in full operation. We may have to wait until results are published or patent applications are filed.

7) I have heard nothing of plans for production of YBG-2000 anywhere other than in the Hinesville, GA. facility. Everything I saw and heard there indicated that, at least for the immediate future, they believe they have room to expand even beyond 4 production lines, if needed. HOWEVER.........if clinical trials in Asia were to conclusively show YBG-2000 to be effective in reducing or eliminating the threat of Avian flue, the whole picture could change overnight.

JMO.

-z